Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance)
Author:
Publisher
Elsevier BV
Subject
Geriatrics and Gerontology,Oncology
Reference22 articles.
1. Preface;Rao;Clin Geriatr Med,2016
2. PRODIGE 20: bevacizumab+chemotherapy (BEV-CT) versus chemotherapy alone (CT) in elderly patients (pts) with untreated metastatic colorectal cancer (mCRC)--a randomized phase II trial;Aparicio;ASCO Meet Abstr,2015
3. Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients;Aparicio;J Clin Oncol,2013
4. Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial;Cunningham;Lancet Oncol,2013
5. Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of capecitabine, bevacizumab and mitomycin C;Price;Ann Oncol,2012
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation;Journal of Clinical Oncology;2023-12-01
2. Age and comorbidity association with survival outcomes in metastatic colorectal cancer: CALGB 80405 analysis;Journal of Geriatric Oncology;2022-05
3. Older adult participation in cancer clinical trials: A systematic review of barriers and interventions;CA: A Cancer Journal for Clinicians;2020-10
4. Strategies to Improve Participation of Older Adults in Cancer Research;Journal of Clinical Medicine;2020-05-22
5. Experiences and hidden needs of older patients, their families and their physicians in palliative chemotherapy decision-making: a qualitative study;Japanese Journal of Clinical Oncology;2020-04-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3